Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Martins WK, Silva M, Pandey Ok, Maejima I, Ramalho E, Olivon VC, et al. Autophagy-targeted remedy to modulate age-related ailments: success, pitfalls, and...
Overview of HIFI spatial evaluation workflowWe purposely designed HIFI to be simple to implement with open-source software program and with out the necessity...
